G250 Antigen-Targeting Drug-Loaded Nanobubbles Combined with Ultrasound Targeted Nanobubble Destruction: A Potential Novel Treatment for Renal Cell Carcinoma.

Zhiping YuYixuan WangDan XuLianhua Zhu Ming HuQiuli LiuWeihua LanJun JiangLuofu Wang

Published in: International journal of nanomedicine (2020)

The combined G250-TNBs and UTND treatment can deliver anti-tumor drugs to local areas of RCC, increase the local effective drug concentration, and enhance anti-tumor efficacy, thus providing a potential novel method for targeted therapy of RCC.

Keyphrases

renal cell carcinoma
cancer therapy
magnetic resonance imaging
drug delivery
human health
combination therapy
adverse drug
smoking cessation